METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

Clinical trial NCT03388190 · COMPLETED

Trial details

NCT number: NCT03388190
Sponsor: University Hospital, Akershus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2018-05-29
Primary completion: 2024-03-18
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.